Cargando…

Capturing patient-reported and quality of life outcomes with use of shorter regimens for drug-resistant tuberculosis: mixed-methods substudy protocol, TB PRACTECAL-PRO

INTRODUCTION: People living with multidrug-resistant tuberculosis currently have few options for effective treatment and cure. Regimens that are available are toxic, may involve injections and take up to 2 years to complete treatment, with success rates as low as 50%. The TB-PRACTECAL trial is evalu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stringer, Beverley, Lowton, Karen, James, Nicola, Nyang'wa, Bern-Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Respiratory Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422308/ https://www.ncbi.nlm.nih.gov/pubmed/34489263 http://dx.doi.org/10.1136/bmjopen-2020-043954

Ejemplares similares

Cost-effectiveness of new MDR-TB regimens: study protocol for the TB-PRACTECAL economic evaluation substudy
por: Sweeney, Sedona, et al.
Publicado: (2020)

Population pharmacokinetics and pharmacodynamics of investigational regimens’ drugs in the TB-PRACTECAL clinical trial (the PRACTECAL-PKPD study): a prospective nested study protocol in a randomised controlled trial
por: Nyang'wa, Bern-Thomas, et al.
Publicado: (2021)

TB-PRACTECAL: study protocol for a randomised, controlled, open-label, phase II–III trial to evaluate the safety and efficacy of regimens containing bedaquiline and pretomanid for the treatment of adult patients with pulmonary multidrug-resistant tuberculosis
por: Berry, Catherine, et al.
Publicado: (2022)

Outcomes with a shorter multidrug-resistant tuberculosis regimen from Karakalpakstan, Uzbekistan
por: du Cros, Philipp, et al.
Publicado: (2021)

Cost-effectiveness of short, oral treatment regimens for rifampicin resistant tuberculosis
por: Sweeney, Sedona, et al.
Publicado: (2022)

Association of BMI Category Change with TB Treatment Mortality in HIV-Positive Smear-Negative and Extrapulmonary TB Patients in Myanmar and Zimbabwe
por: Benova, Lenka, et al.
Publicado: (2012)

TB research requires strong protections, innovation, and increased funding in response to COVID-19
por: Nyang’wa, B. T., et al.
Publicado: (2021)

Optimising recruitment to a late-phase tuberculosis clinical trial: a qualitative study exploring patient and practitioner experiences in Uzbekistan
por: Wharton-Smith, Alexandra, et al.
Publicado: (2021)

Shorter TB treatment regimens should be safer as well
por: Rucsineanu, O., et al.
Publicado: (2023)

Cash transfer scheme for people with tuberculosis treated by the National TB Programme in Western India: a mixed methods study
por: Patel, Bharatkumar Hargovandas, et al.
Publicado: (2019)

Implementation of the ‘Removed Injectable modified Short-course regimens for EXpert Multidrug Resistant Tuberculosis’ (RISE study) in Tanzania: a protocol for a mixed-methods process evaluation
por: Kalolo, Albino, et al.
Publicado: (2022)

High prevalence of subclinical tuberculosis in HIV-1-infected persons without advanced immunodeficiency: implications for TB screening
por: Oni, Tolu, et al.
Publicado: (2011)

Limited Scope of Shorter Drug Regimen for MDR TB Caused by High Resistance to Fluoroquinolone
por: Singh, Pravin K., et al.
Publicado: (2019)

High success and low recurrence with shorter treatment regimen for multidrug-resistant TB in Nepal
por: Koirala, S., et al.
Publicado: (2021)

Prospective study on outcome of MDR-TB using the shorter regimen during COVID-19 pandemic
por: Kumar, G Sravan, et al.
Publicado: (2023)

Can Pan-TB shorter regimens be a promising hope for ending TB in India by 2025 in ongoing COVID-19 era?
por: Prasad, Rajendra, et al.
Publicado: (2022)

Aetiology of acute respiratory infection in preschool children requiring hospitalisation in Europe—results from the PED-MERMAIDS multicentre case–control study
por: Kohns Vasconcelos, Malte, et al.
Publicado: (2021)

Early risk assessment in paediatric and adult household contacts of confirmed tuberculosis cases by novel diagnostic tests (ERASE-TB): protocol for a prospective, non-interventional, longitudinal, multicountry cohort study
por: Marambire, Edson Tawanda, et al.
Publicado: (2022)

Better programmatic outcome with the shorter regimen for the treatment of multidrug-resistant tuberculosis (MDR-TB) in Guinea: A retrospective cohort study
por: Hassane-Harouna, Souleymane, et al.
Publicado: (2020)

Ocrelizumab shorter infusion: Primary results from the ENSEMBLE PLUS substudy in patients with MS
por: Hartung, Hans-Peter
Publicado: (2020)

Safety evaluation of shorter infusion for ocrelizumab in a substudy of the Phase IIIb CHORDS trial
por: Bermel, Robert A., et al.
Publicado: (2021)

Impact of diabetes mellitus on clinical parameters and treatment outcomes of newly diagnosed pulmonary tuberculosis patients in Thailand
por: Duangrithi, D, et al.
Publicado: (2013)

Accelerating development of new shorter TB treatment regimens in anticipation of a resurgence of multi-drug resistant TB due to the COVID-19 pandemic
por: Tiberi, Simon, et al.
Publicado: (2021)

Perspectives of mild asthma patients on maintenance versus as-needed preventer treatment regimens: a qualitative study
por: Foster, Juliet, et al.
Publicado: (2022)

Drug-resistant tuberculosis: Progress towards shorter and safer regimens
por: Saravu, Kavitha, et al.
Publicado: (2019)

Should opioids be used for breathlessness and in whom? A PRO and CON debate of the evidence
por: Ekström, Magnus, et al.
Publicado: (2023)

Study protocol for a randomised controlled trial assessing the impact of pulmonary rehabilitation on maximal exercise capacity for adults living with post-TB lung disease: Global RECHARGE Uganda
por: Katagira, Winceslaus, et al.
Publicado: (2021)

Towards all-oral and shorter treatment regimens for drug-resistant tuberculosis
por: Weyer, Karin, et al.
Publicado: (2018)

IMPACT study on intervening with a manualised package to achieve treatment adherence in people with tuberculosis: protocol paper for a mixed-methods study, including a pilot randomised controlled trial
por: Stagg, Helen R, et al.
Publicado: (2019)

Factors associated with treatment outcome of MDR/RR-TB patients treated with shorter injectable based regimen in West Java Indonesia
por: Soeroto, Arto Yuwono, et al.
Publicado: (2022)

Release of ATP and glutamate in the nucleus tractus solitarii mediate pulmonary stretch receptor (Breuer–Hering) reflex pathway
por: Gourine, Alexander V, et al.
Publicado: (2008)

A retrospective database study comparing treatment outcomes and cost associated with choice of fixed-dose inhaled corticosteroid/long-acting β(2)-agonists for asthma maintenance treatment in Germany
por: Aballéa, S, et al.
Publicado: (2008)

Study of the burden on patients with chronic obstructive pulmonary disease
por: Izquierdo, J L, et al.
Publicado: (2009)

The increase in pulmonary arterial pressure caused by hypoxia depends on iron status
por: Smith, Thomas G, et al.
Publicado: (2008)

Optimising treatment for COPD – new strategies for combination therapy
por: Welte, T
Publicado: (2009)

A comparison of budesonide/formoterol maintenance and reliever therapy vs. conventional best practice in asthma management
por: Louis, R, et al.
Publicado: (2009)

Oxygen sensitivity of mitochondrial function in rat arterial chemoreceptor cells
por: Buckler, Keith J, et al.
Publicado: (2013)

Carotid body hyperplasia and enhanced ventilatory responses to hypoxia in mice with heterozygous deficiency of PHD2
por: Bishop, Tammie, et al.
Publicado: (2013)

Impaired CO(2) sensitivity of astrocytes in a mouse model of Rett syndrome
por: Turovsky, Egor, et al.
Publicado: (2015)

Impact of changes to reimbursement of fixed combinations of inhaled corticosteroids and long-acting β(2)-agonists in obstructive lung diseases: a population-based, observational study
por: Björnsdóttir, U S, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_u6k959rs6q9ck0nus1s2tp37mf